Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 202.50

-2.7%

Nov 7 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (16611)	3/6/1998 4:04:00 PM
From: Abuckatatime	Read Replies (4) of 32384

Henry, re: <<implications for oral version of GM-CSF are very strong>>. Agreed. And exciting. IMNX's Leukine, an injectible GM-CSF, is used following chemo in acute myelogenous leukemia, in accelerating recovery following marrow transplantation (eg for treatment of cancer), and has been shown to lengthen survival of melanoma patients. It may have other indications as well, I'm not sure. Looks like an oral GM-CSF could tap into a sizeable market. Anyone know what revenues Leukine generates for IMNX? Greg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next